These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3877113)

  • 41. Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol.
    Valla D; Gaudin C; Geoffroy P; Braillon A; Lee SS; Lebrec D
    J Hepatol; 1987 Feb; 4(1):86-92. PubMed ID: 3494761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the portal hypertensive patient.
    Bosch J; Pagán JC; Bruix J; Ruiz del Arbol L; Pizcueta MP; Navasa M; Feu F; Bru C; Rodés J
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():39-47. PubMed ID: 2519083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical physiologic approach to the patient with portal hypertension.
    Chiandussi L
    Bull N Y Acad Med; 1975 Apr; 51(4):557-64. PubMed ID: 1091318
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
    Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
    J Hepatol; 1987 Feb; 4(1):71-9. PubMed ID: 3033061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Portal hypertension.
    Bosch J; Navasa M; Garcia-Pagán JC; DeLacy AM; Rodés J
    Med Clin North Am; 1989 Jul; 73(4):931-53. PubMed ID: 2657268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure.
    Taourel P; Blanc P; Dauzat M; Chabre M; Pradel J; Gallix B; Larrey D; Bruel JM
    Hepatology; 1998 Oct; 28(4):932-6. PubMed ID: 9755228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis.
    Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Yokosuka O
    World J Gastroenterol; 2015 Aug; 21(29):8894-902. PubMed ID: 26269679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of non-shunting operation on azygos venous blood flow in cirrhotic patients.
    Kokudo N; Kawasaki S; Ohashi K; Sakamoto H; Koyama H; Sanjo K; Idezuki Y
    Gut; 1989 Oct; 30(10):1396-400. PubMed ID: 2583566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
    Jones AL; Bangash IH; Walker J; Simpson KJ; Finlayson ND; Hayes PC
    Gut; 1995 Jan; 36(1):104-9. PubMed ID: 7890211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial.
    Henderson JM; Kutner MH; Millikan WJ; Galambos JT; Riepe SP; Brooks WS; Bryan FC; Warren WD
    Ann Intern Med; 1990 Feb; 112(4):262-9. PubMed ID: 2404448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol.
    Braillon A; Moreau R; Hadengue A; Roulot D; Sayegh R; Lebrec D
    J Hepatol; 1989 Nov; 9(3):312-8. PubMed ID: 2607120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid change of liver stiffness after variceal ligation and TIPS implantation.
    Piecha F; Paech D; Sollors J; Seitz HK; Rössle M; Rausch V; Mueller S
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G179-G187. PubMed ID: 29051188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of breath-hold 2D phase-contrast with non breath-hold cine phase-contrast MRA in the assessment of azygos venous blood flow in portal hypertension.
    Ng WH; Chan YL; Sung JY; Lee YT; Lee SF; Chung SS
    MAGMA; 2004 Apr; 16(5):211-7. PubMed ID: 15022053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of vasopressin on left gastric venous flow in cirrhotic patients with esophageal varices.
    Ohnishi K; Sato S
    Am J Gastroenterol; 1990 Mar; 85(3):293-5. PubMed ID: 2178400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The postprandial portal flow is related to the severity of portal hypertension and liver cirrhosis.
    Ludwig D; Schwarting K; Korbel CM; Brüning A; Schiefer B; Stange EF
    J Hepatol; 1998 Apr; 28(4):631-8. PubMed ID: 9566832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of vasopressin on portal venous pressure.
    Kallio H; Lempinen M
    Acta Chir Scand; 1983; 149(1):49-52. PubMed ID: 6601347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of complications of portal hypertension.
    Rossi RL; Jenkins RL; Nielsen-Whitcomb FF
    Surg Clin North Am; 1985 Apr; 65(2):231-62. PubMed ID: 3874438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Splenomegaly and variceal bleeding--hemodynamic basis and treatment implications.
    Gusberg RJ; Peterec SM; Sumpio BE; Meier GH
    Hepatogastroenterology; 1994 Dec; 41(6):573-7. PubMed ID: 7721248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medical treatment of portal hypertension and oesophageal varices.
    Hayes PC; Shepherd AN; Bouchier IA
    Br Med J (Clin Res Ed); 1983 Sep; 287(6394):733-6. PubMed ID: 6137257
    [No Abstract]   [Full Text] [Related]  

  • 60. [The significance of disturbances of draining functions of the azygos vein in pathogenesis of varicose dilatation of the veins of the esophagus and stomach in portal hypertension (experimental-clinical investigation)].
    Turmakhanov ST; Andreev GN; Borisova NA
    Vestn Khir Im I I Grek; 2004; 163(4):17-20. PubMed ID: 15626067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.